Bclxl Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
BCLXL (BCL2-Like 1) is an anti-apoptotic member of the BCL2 family that inhibits apoptosis by sequestering pro-apoptotic BAX and BAK. It is an alternatively spliced isoform of BCL2L1.
BCLXL is a 26 kDa protein that resides in the mitochondrial outer membrane, endoplasmic reticulum, and nucleus. Unlike BCL2, BCLXL is essential for embryonic development and adult tissue homeostasis, particularly in the nervous system.
BCLXL contains:
BCLXL functions in:
BCLXL is neuroprotective in:
BCLXL inhibitors are used in cancer therapy. Conversely, BCLXL activators or stabilizers are being explored for neuroprotection.
The study of Bclxl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.